|
Symbol Name ID |
Acan aggrecan MGI:99602 |
Allele Symbol
Name Chr Synonyms Category Phenotypic Classes Human Diseases
Acanb2b183Clo
aggrecan; Bench to Bassinet Program (B2B/CVDC), mutation 183 Cecilia Lo
7 Sancho Panza Chemically induced (ENU) cardiovascular, craniofacial, digestive/alimentary, growth/size, limbs/digits/tail, muscle
Acancmd
aggrecan; cartilage matrix deficiency
7 Spontaneous behavior, craniofacial, digestive/alimentary, growth/size, hearing/vestibular/ear, homeostasis, limbs/digits/tail, liver/biliary, mortality/aging, nervous system, respiratory, skeleton Achondroplasia; ACH 100800
Acancmd-Bc
aggrecan; cartilage matrix deficiency British Columbia 7 cmd-Bc Spontaneous craniofacial, digestive/alimentary, growth/size, limbs/digits/tail, mortality/aging, respiratory
Acantm1Afos
aggrecan; targeted mutation 1, Amanda J Fosang 7 Chloe Targeted (knock-in) no abnormal phenotype observed
Acantm1(cre/ERT2)Crm
aggrecan; targeted mutation 1, Benoit de Crombrugghe 7 Agc1tm(IRES-creERT2) Targeted (knock-in) no abnormal phenotype observed
Acantm2Afos
aggrecan; targeted mutation 2, Amanda J Fosang 7 Jaffa Targeted (knock-in) immune, skeleton
Acantm1a(EUCOMM)Hmgu
aggrecan; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH 7 Targeted (Floxed/Frt)
(Cell Line)
Acantm1e(EUCOMM)Hmgu
aggrecan; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH 7 Targeted (Reporter)
(Cell Line)
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc |
||
|
Citing These Resources Funding Information Warranty Disclaimer & Copyright Notice Send questions and comments to User Support. |
last database update 06/05/2013 MGI 5.13 |
|
|
|
||